Scarica l'app Stockscreener
9.24
18.31%
1.43
Dopo l'orario di chiusura:
9.61
0.37
+4.00%
Precedente Chiudi:
$7.81
Aprire:
$7.8
Volume 24 ore:
824.99K
Relative Volume:
1.85
Capitalizzazione di mercato:
$59.12M
Reddito:
-
Utile/perdita netta:
$-26.96M
Rapporto P/E:
-1.0613
EPS:
-8.7061
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
+35.68%
1M Prestazione:
+175.82%
6M Prestazione:
+60.42%
1 anno Prestazione:
+51.23%
Intervallo 1D:
$7.2101
$9.30
Intervallo di 1 settimana:
$6.07
$9.30
Portata 52W:
$2.07
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Nome
Quantum Biopharma Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare QNTM vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
9.24 | 49.97M | 0 | -26.96M | -8.25M | -8.7061 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
QNTM Should I Buy - Intellectia AI
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH - Moomoo
Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - NewMediaWire
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study - TipRanks
Quantum BioPharma (QNTM) Achieves Key Enrollment Milestone in MS Study - GuruFocus
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM) - Yahoo Finance
Quantum BioPharma reaches midpoint in MGH MS imaging study - grafa.com
Quantum BioPharma stock surges on MS imaging study progress - Investing.com
Quantum BioPharma stock surges on MS imaging study progress By Investing.com - Investing.com Canada
Quantum BioPharma Hits Midpoint in MGH Imaging Study as Lucid-MS Advances Toward Phase 2 - TipRanks
Quantum BioPharma (NASDAQ: QNTM) advances MS imaging and Lucid-MS plans - Stock Titan
Quantum BioPharma Ltd. Achieves Halfway Point in Collaborative MS Imaging Study with Massachusetts General Hospital - Quiver Quantitative
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with ... - Enidnews.com
New MS PET scan in MGH-Quantum trial shows robust myelin damage signals - Stock Titan
QNTM Stock Price, Quote & Chart | QUANTUM BIOPHARMA-B SUB VOT (NASDAQ:QNTM) - ChartMill
Quantum BioPharma Boosts Liquidity and Advances Lucid-MS as U.S. Court Backs Market-Manipulation Suit - TipRanks
Number of shareholders of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – MUN:0K91 - TradingView
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026 - Stock Titan
Lucid-MS IND filing and longer cash runway at Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum Biopharma Posts Higher Assets but Swings to Shareholders’ Deficit in Q1 2026 Filing - TipRanks
Quantum BioPharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan
Quantum BioPharma Provides Corporate Update - The Manila Times
Top Cannabis Stocks To Follow NowApril 27th - MarketBeat
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
Quantum Biopharma bolsters Bitcoin treasury - MSN
Quantum BioPharma announces private placement - MSN
Cannabis Stocks To Watch NowApril 22nd - MarketBeat
Quantum BioPharma’s Unbuzzd Licensee Names New CEO to Drive U.S. Rollout of Clinically Backed Hangover Beverage - TipRanks
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - The Manila Times
Unbuzzd’s new CEO to drive U.S. rollout for Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum BioPharma Ltd. Announces Appointment of Richard Buzbuzian as CEO of Unbuzzd Wellness Inc. to Drive Commercialization of Innovative Beverage - Quiver Quantitative
Hangover remedy maker Unbuzzd picks CEO for rollout in Florida and Texas - Stock Titan
Promising Cannabis Stocks To Follow TodayApril 21st - MarketBeat
Quantum (QNTM) Stock: Momentum Behavior Insight (Slight Rise) 2026-04-20Shared Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent
Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets
Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire
Can Quantum (QNTM) Stock Beat Estimates | Price at $3.58, Down 10.05%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):